Edwards Lifesciences 2005 Annual Report"
This experimental, proprietary technology is designed to treat patients
with severe aortic heart valve stenosis by threading a replacement heart
valve via a catheter through the patient’s circulatory system.
Percutaneous heart valve replacement and repair represent an important
therapeutic opportunity for patients, and Edwards leads the field with
the most advanced and comprehensive platform of technologies in development.
These new therapies offer the promise of less-invasive treatments, shorter
hospital stays and faster recovery times for patients.
